Renal Dialysis
Hepatitis B virus infection is a major issue among dialysis patients and can result in liver disease. The unique clinical course of this condition makes it more likely that complications will develop, as inflammation or fibrosis are prominent features during the early stages for many people who contract hepatitis B.
Multiple methods can be used to diagnose hepatitis B infection in dialysis patients. The most common method is through a blood test called the hepatitis B surface antigen (HBsAg) test. This test looks for the presence of HBsAg, a protein found on the surface of the virus in the blood. If this protein is present, it indicates that an individual has an active hepatitis B infection. Other tests that may diagnose hepatitis B include the anti-HBc test, the HBeAg test, and the hepatitis B DNA test.
The goal of treatment for hepatitis B infection is to suppress the virus and prevent further damage to the liver. Several antiviral medications can treat hepatitis B infection, including entecavir, lamivudine, tenofovir alafenamide, and telbivudine. These medications can help reduce the amount of virus in the body. In some cases, a liver transplant may be necessary to treat hepatitis B infection.
